Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 71368-71369 [2023-22752]

Download as PDF 71368 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices • Part C Organization Determinations, Appeals, and Grievances (ODAG) • Special Needs Plans Care Coordination (SNPCC) ddrumheller on DSK120RN23PROD with NOTICES1 CMS generally conducts program audits at the parent organization level in an effort to reduce burden and, for routine audits, subjects each sponsoring organization to all applicable program area protocols. For example, if a sponsoring organization does not offer a special needs plan, or an accrediting organization has deemed a special needs plan compliant with CMS regulations and standards, CMS would not apply the SNPCC protocol. Likewise, CMS would not apply the ODAG audit protocol to an organization that offers only a standalone prescription drug plan since that organization does not offer the MA benefit. Conversely, ad hoc audits resulting from referral may be limited in scope and, therefore, all program area protocols may not be applied. The information gathered during this program audit will be used by the Medicare Parts C and D Oversight and Enforcement Group (MOEG) within the Center for Medicare (CM) and CMS Regional Offices to assess sponsoring organizations’ compliance with Medicare program requirements. If outliers or other data anomalies are detected, Regional Offices will work in collaboration with MOEG and other divisions within CMS for follow-up and resolution. Additionally, MA and Part D organizations will receive the audit results and will be required to implement corrective action to correct any identified deficiencies. Form Number: CMS–10717 (OMB control number: 0938–1395); Frequency: Yearly; Affected Public: Private Sector, State, Local, or Tribal Governments, Federal Government, Business or other forprofits, Not-for-Profit Institutions; Number of Respondents: 182; Total Annual Responses: 182; Total Annual Hours: 36,444. (For policy questions regarding this collection contact Matthew Guerand, at 303–844–7120.) Dated: October 11, 2023. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2023–22791 Filed 10–13–23; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 17:03 Oct 13, 2023 Jkt 262001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice of Fiscal Year 2023 Health Center Program COVID–19 HHS Bridge Access Program Funding Awards Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of funding awards. submit data on program activities through the HRSA Health Center COVID–19 survey as required, as well as periodic progress reports. Carole Johnson, Administrator. [FR Doc. 2023–22751 Filed 10–13–23; 8:45 am] BILLING CODE 4165–15–P AGENCY: In support of the HHS Bridge Access Program for COVID–19 Vaccines and Treatments, HRSA provided more than $81 million in one-time funding to all current Health Center Program operational (H80) award recipients and to health center look-alikes that previously received American Rescue Plan funding (L2C awards). FOR FURTHER INFORMATION CONTACT: Olivia Shockey, Expansion Division Director, HRSA, at oshockey@hrsa.gov and (301) 594–4300. SUPPLEMENTARY INFORMATION: Intended Recipient of the Award: The total amount of funding, number of awards, and award recipients can be found here: https://bphc.hrsa.gov/ funding/coronavirus-related-funding/ covid-19-bridge-funding/fy-2023awards. Project Period: September 1, 2023— December 31, 2024. CFDA Number: 93.527. Authority: Section 2401 of the American Rescue Plan Act of 2021, Public Law 117–2. Justification: The end of the declared COVID–19 Public Health Emergency and associated transition to commercial access to vaccines and therapeutics impacts the capacity of health centers to maintain essential COVID–19 related services for their patients, including but not limited to health center patients who lack health insurance. Health centers will use one-time Bridge funding to support uninsured and underinsured patients and residents of their communities with needs such as COVID–19 vaccination and therapeutics, enabling/patient support services (such as outreach, education, enrollment assistance, transportation, translation, and care coordination) to support COVID–19 related services; community COVID–19 vaccination events; and, supplies and personnel who support COVID–19 related services and care delivery, including personnel costs necessary to develop, support, or expand collaborations, including collaborations with state/jurisdiction immunization programs. Recipients will SUMMARY: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council on Alzheimer’s Research, Care, and Services; Meeting Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. AGENCY: This notice announces the public meeting of the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer’s disease and related dementias (ADRD) on people with the disease and their caregivers. During the meeting on October 30, 2023, the Advisory Council will welcome a new cohort of members and hear updates from federal agencies on key activities over the last quarter. A panel will present information on interventions to reduce the risk of developing dementia. DATES: The meeting will be held virtually on October 30 from 12 p.m. to 4:30 p.m. EDT. ADDRESSES: The meeting will be virtual. It will stream live at www.hhs.gov/live. Comments: Time is allocated on the agenda to hear public comments from 4 p.m. to 4:30 p.m. The time for oral comments will be limited to two (2) minutes per individual. In order to provide a public comment, please register by emailing your name to napa@hhs.gov by Thursday, October 26. Registered commenters will receive both a dial-in number and a link to join the meeting virtually; individuals will have the choice to either join virtually via the link, or to call in only by using the dialin number. Note: There may be a 30–45 second delay in the livestream video presentation of the conference. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. All participant audio lines will be muted for the duration of the meeting and only unmuted by the Host at the time of the SUMMARY: E:\FR\FM\16OCN1.SGM 16OCN1 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices participant’s public comment. Should you have questions during the session email napa@hhs.gov and someone will respond to your message as quickly as possible. In order to ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@ hhs.gov by Wednesday, November 1, 2023. These comments will be shared on the website and reflected in the meeting minutes. In lieu of oral comments, formal written comments may be submitted for the record by Wednesday, November 1, 2023 to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@ hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202–260–6075, helen.lamont@hhs.gov. Note: The meeting will be available to the public live at www.hhs.gov/live. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: dementia, risk reduction, Alzheimer’s disease. Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer’s Project Act website when available, after the meeting. Authority: 42 U.S.C. 11225; section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: September 22, 2023. Miranda Lynch-Smith, Senior Official Performing the Duties of the Assistant Secretary for Planning and Evaluation, Deputy Assistant Secretary for Health Policy. [FR Doc. 2023–22752 Filed 10–13–23; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Committee on Vital and Health Statistics Centers for Disease Control and Prevention, HHS. ACTION: Notice of meeting (virtual); notice of request for information (RFI). AGENCY: VerDate Sep<11>2014 17:03 Oct 13, 2023 Jkt 262001 71369 SUMMARY: Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting and related Request for Information (RFI). This meeting is open to the public. The public is welcome to obtain the link to attend this meeting by following the instructions posted on the Committee website: https://ncvhs.hhs.gov/ meetings/full-committee-meeting-15. To submit comments in response to the RFI, please send by close of business January 12, 2024, to NCVHSmail@ cdc.gov, and include on the subject line: Response from [your organization and/ or name] regarding ICD–11 RFI. Name: National Committee on Vital and Health Statistics (NCVHS) Meeting. DATES: Wednesday, November 29, 2023: 10 a.m.–5 p.m. ET. Thursday, November 30, 2023: 10 a.m.–4:30 p.m. ET. ADDRESSES: Virtual open meeting. FOR FURTHER INFORMATION CONTACT: Substantive program information may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, or via electronic mail to vgh4@ cdc.gov; or by telephone (301) 458– 4715. Summaries of meetings and a roster of Committee members are available on the NCVHS website https:// ncvhs.hhs.gov/ where further information including an agenda and instructions to access the broadcast of the meeting will be posted. Should you require reasonable accommodation, please telephone the CDC Office of Equal Employment Opportunity at (770) 488–3210 as soon as possible. SUPPLEMENTARY INFORMATION: Name: National Committee on Vital and Health Statistics (NCVHS). Full Committee Meeting. The National Committee on Vital and Health Statistics was established by Congress to serve as the statutory [42 U.S.C. 242k(k)] advisory body to the Secretary of Health and Human Services for health data, statistics, privacy, and national health information policy. In addition, under the Health Insurance Portability and Accountability Act of 1996 (HIPAA),1 NCVHS advises the Secretary on administrative simplification standards, including those for privacy, security, adoption and implementation of transaction standards, unique identifiers, code sets, and operating rules adopted under the Patient Protection and Affordable Care Act (ACA) 2 and HIPAA. In that capacity, the Committee provides advice and assistance to the Department and serves as a forum for interaction with interested private sector groups on health data issues. It fulfills important review and advisory functions regarding health data and administrative standards of national and international scope, conducts studies of prevailing current topics, and makes recommendations for improvement of the Nation’s health statistics and information systems. Purpose: The meeting agenda will include briefings from HHS officials, time for members to discuss and consider current and proposed activities outlined in the NCVHS 2023–24 workplan, and hold discussions on several health data policy topics, including health care standards development and cybersecurity. The Subcommittee on Standards plans to hold a panel discussion on the approach used by Standards Development Organizations (SDOs) to evaluate and assess the readiness of new and updated standards prior to release for national implementation. This includes discussion on potential risks and impacts across existing standards, calculation of business cost recovery, and planning for the anticipated ICD–11 implementation timeline and expected milestones. Additional briefings on related topics such as HIPAA enforcement also may be included on the agenda. The NCVHS Workgroup on Timely and Strategic Action to Inform ICD–11 Policy will report to the full Committee on recent activities, including information learned from the ICD–11 Expert Roundtable meeting held August 3, 2023, and its anticipated workplan in the upcoming 6–12 month period. The Subcommittee on Privacy, Confidentiality, and Security will facilitate a discussion on proposed recommendations to HHS to strengthen the HIPAA Security Rule following recent Committee briefings on the topic. Finally, the Committee will allot time to discuss draft language for the Committee’s 2023 Report to Congress. The Committee will also reserve time on the agenda for public comment. Meeting times and topics are subject to change. Please refer to the agenda posted on the NCVHS website for 1 Public Law 104–191, 110 Stat. 1936 (Aug 21, 1996), available at https://www.congress.gov/104/ plaws/publ191/PLAW-104publ191.pdf. 2 Public Law 111–148, 124 Stat.119, available at https://www.congress.gov/111/plaws/publ148/ PLAW-111publ148.pdf. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71368-71369]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22752]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias (ADRD) on people 
with the disease and their caregivers. During the meeting on October 
30, 2023, the Advisory Council will welcome a new cohort of members and 
hear updates from federal agencies on key activities over the last 
quarter. A panel will present information on interventions to reduce 
the risk of developing dementia.

DATES: The meeting will be held virtually on October 30 from 12 p.m. to 
4:30 p.m. EDT.

ADDRESSES: The meeting will be virtual. It will stream live at 
www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4 p.m. to 4:30 p.m. The time for oral comments will be limited to 
two (2) minutes per individual. In order to provide a public comment, 
please register by emailing your name to [email protected] by Thursday, 
October 26. Registered commenters will receive both a dial-in number 
and a link to join the meeting virtually; individuals will have the 
choice to either join virtually via the link, or to call in only by 
using the dial-in number. Note: There may be a 30-45 second delay in 
the livestream video presentation of the conference. For this reason, 
if you have pre-registered to submit a public comment, it is important 
to connect to the meeting by 3:45 p.m. to ensure that you do not miss 
your name and allotted time when called. If you miss your name and 
allotted time to speak, you may not be able to make your public 
comment. All participant audio lines will be muted for the duration of 
the meeting and only unmuted by the Host at the time of the

[[Page 71369]]

participant's public comment. Should you have questions during the 
session email [email protected] and someone will respond to your message as 
quickly as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Wednesday, November 
1, 2023. These comments will be shared on the website and reflected in 
the meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Wednesday, November 1, 2023 to Helen Lamont, Ph.D., 
OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. 
Comments may also be sent to [email protected]. Those submitting written 
comments should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: dementia, risk reduction, Alzheimer's 
disease.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.
    Authority: 42 U.S.C. 11225; section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: September 22, 2023.
Miranda Lynch-Smith,
Senior Official Performing the Duties of the Assistant Secretary for 
Planning and Evaluation, Deputy Assistant Secretary for Health Policy.
[FR Doc. 2023-22752 Filed 10-13-23; 8:45 am]
BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.